Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 12:19 pm Purchase | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,738,206 5.56% | 6,738,206 (New Position) | View |
| 2020-02-14 12:17 pm Purchase | 13G | ADMA BIOLOGICS INC ADMA | Consonance Capital Management LP | 5,166,961 8.71% | 578,609 (+12.61%) | View |
| 2020-01-09 4:59 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Consonance Capital Management LP | 0 0% | -5,171,464 (Position Closed) | View |
| 2019-12-09 4:37 pm Sale | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Consonance Capital Management LP | 5,171,464 5.02% | -8,089,499 (-61.00%) | View |
| 2019-09-06 5:17 pm Sale | 13D | PACIRA BIOSCIENCES INC PCRX | Consonance Capital Management LP | 2,075,970 4.9% | -264,119 (-11.29%) | View |
| 2019-08-05 4:09 pm Sale | 13D | PACIRA BIOSCIENCES INC PCRX | Consonance Capital Management LP | 2,340,089 5.7% | -449,827 (-16.12%) | View |
| 2019-07-10 3:48 pm Sale | 13D | PACIRA BIOSCIENCES INC PCRX | Consonance Capital Management LP | 2,789,916 6.8% | -415,643 (-12.97%) | View |
| 2019-06-05 12:57 pm Sale | 13D | PACIRA BIOSCIENCES INC PCRX | Consonance Capital Management LP | 3,205,559 7.8% | -446,575 (-12.23%) | View |